GE HealthCare Technologies Inc. Share Price Börse Stuttgart

Equities

L0T

US36266G1076

Advanced Medical Equipment & Technology

Real-time Estimate Tradegate 14:28:30 04/06/2024 BST 5-day change 1st Jan Change
70.93 EUR -1.60% Intraday chart for GE HealthCare Technologies Inc. -2.63% +0.51%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site

Financials

Sales 2024 * 20.16B 18.56B 1,580B Sales 2025 * 21.16B 19.48B 1,658B Capitalization 35.22B 32.42B 2,760B
Net income 2024 * 1.86B 1.71B 146B Net income 2025 * 2.12B 1.95B 166B EV / Sales 2024 * 2 x
Net Debt 2024 * 5.16B 4.75B 404B Net Debt 2025 * 3.16B 2.91B 248B EV / Sales 2025 * 1.81 x
P/E ratio 2024 *
19 x
P/E ratio 2025 *
16.8 x
Employees 51,000
Yield 2024 *
0.12%
Yield 2025 *
0.22%
Free-Float 93.06%
More Fundamentals * Assessed data
Dynamic Chart
GE HealthCare, Tampa General Hospital Expand Collaboration in Imaging, Ultrasound Technology MT
GE Healthcare and Tampa General Hospital Expand Long-Term Partnership to Benefit Patients and Clinicians Across the State of Florida CI
Goldman Sachs Initiates GE HealthCare Technologies With Neutral Rating, $87 Price Target MT
GE Healthcare Names Adam Holton as Chief People Officer CI
Some of the biggest splits in Corporate America RE
GE HealthCare Technologies Insider Sold Shares Worth $7,109,427, According to a Recent SEC Filing MT
Transcript : GE HealthCare Technologies Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 10:00 AM
GE Healthcare and Medis Medical Imaging Announces Collaboration Focused on Non-Invasive Coronary Assessments to Help Advance Precision Care in Treatment of Coronary Artery Disease CI
GE HealthCare Unveils SIGNA MAGNUS, an FDA 510(K) Pending Head-Only Magnetic Resonance (MR) Scanner Designed to Explore Advance Advancements in Neuro Science CI
Mizuho Adjusts Price Target on GE HealthCare Technologies to $105 From $110 MT
GE HealthCare Launches New Era of AI-Enhanced, Personalized Oncology Solutions at ESTRO 2024 Congress CI
Jefferies Adjusts Price Target on GE HealthCare Technologies to $87 From $92 MT
Health Care Flat Amid Mixed Earnings -- Health Care Roundup DJ
Equity Markets Slide Ahead of Fed Rate Decision MT
Equity Markets Drop Ahead of Fed Rate Decision MT
More news
1 day-1.62%
1 week-2.63%
Current month-2.63%
1 month-4.12%
3 months-17.22%
6 months+10.80%
Current year+0.51%
More quotes
1 week
70.33
Extreme 70.33
72.26
1 month
70.33
Extreme 70.33
76.99
Current year
65.00
Extreme 65
86.50
1 year
58.50
Extreme 58.5
86.50
3 years
51.81
Extreme 51.81
86.50
5 years
51.81
Extreme 51.81
86.50
10 years
51.81
Extreme 51.81
86.50
More quotes
Managers TitleAgeSince
Chief Executive Officer 59 13/12/22
Director of Finance/CFO 51 31/05/23
Chief Tech/Sci/R&D Officer - 30/09/22
Members of the board TitleAgeSince
Director/Board Member 65 13/12/22
Chief Executive Officer 59 13/12/22
Chairman 60 02/01/23
More insiders
Date Price Change Volume
04/06/24 70.36 -2.39% 50
03/06/24 72.08 -0.25% 3
29/05/24 72.26 -0.17% 197

Delayed Quote Börse Stuttgart, June 04, 2024 at 12:03 pm

More quotes
GE HealthCare Technologies Inc. is a medical technology, pharmaceutical diagnostics, and digital solutions company. It develops, manufactures, and markets a portfolio of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients. Its segments include Imaging, Ultrasound, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a comprehensive portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its Ultrasound segment includes ultrasound medical devices and solutions with a portfolio of continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment portfolio is comprised of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment is comprised of two business lines: contrast media and molecular imaging.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
77.15 USD
Average target price
92.74 USD
Spread / Average Target
+20.20%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW